Project Number 1R21NS109884-01 Agency/Funding Organization NINDS Funding Year 2019 View Full Project Details for Normal and abnormal control of APP signaling Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 1. Amyloid beta c. APP and Amyloid beta Signaling Researcher and Organization Principal Investigator COPENHAVER, PHILIP F Principal Investigator First Name PHILIP F Principal Investigator Last Name COPENHAVER Awardee Organization OREGON HEALTH & SCIENCE UNIVERSITY Awardee State Oregon Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-358: NINDS Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) FY Overall Cost $231,000 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official CORRIVEAU, RODERICK A
